Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gore

Showing results (141-150 of 306) with videos related to

Pageof 31
Sort By:
Haematologica|November 13, 2012
Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adultsDan P Zandberg, Ting-Ying Huang, Xuehua Ke, et al.
Journal of Comparative Effectiveness Research|August 15, 2015
Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromesAmer M Zeidan, Franklin Hendrick, Erika Friedmann, et al.
Cancer|March 13, 2016
Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromesAmer M Zeidan, Rong Wang, Amy J Davidoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or hematologic malignanciesMichelle A Rudek, Ming Zhao, Ping He, et al.
Journal of Oncology Practice|January 8, 2015
Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part DAmy J Davidoff, Franklin B Hendrick, Amer M Zeidan, et al.
Cancer|June 23, 2017
Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantationLucy Hui, Gottfried von Keudell, Rong Wang, et al.
Indian Journal of Pharmacology|June 13, 2015
A retrospective study of use of polyvalent anti-snake venom and risk factors for mortality from snake bite in a tertiary care settingShraddha M Pore, Sunita J Ramanand, Praveenkumar T Patil, et al.
American Journal of Public Health|May 10, 2011
Associations of fast food restaurant availability with dietary intake and weight among African Americans in the Jackson Heart Study, 2000-2004Demarc A Hickson, Ana V Diez Roux, Adam E Smith, et al.
Research Square|June 5, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroidsBeverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Cancer Chemotherapy and Pharmacology|September 12, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroidsBeverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Pageof 31

Showing results (141-150 of 306) with videos related to

Sort By:
Pageof 31
Haematologica|November 13, 2012
Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adultsDan P Zandberg, Ting-Ying Huang, Xuehua Ke, et al.
Journal of Comparative Effectiveness Research|August 15, 2015
Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromesAmer M Zeidan, Franklin Hendrick, Erika Friedmann, et al.
Cancer|March 13, 2016
Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromesAmer M Zeidan, Rong Wang, Amy J Davidoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2005
Pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or hematologic malignanciesMichelle A Rudek, Ming Zhao, Ping He, et al.
Journal of Oncology Practice|January 8, 2015
Patient cost sharing and receipt of erythropoiesis-stimulating agents through medicare part DAmy J Davidoff, Franklin B Hendrick, Amer M Zeidan, et al.
Cancer|June 23, 2017
Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantationLucy Hui, Gottfried von Keudell, Rong Wang, et al.
Indian Journal of Pharmacology|June 13, 2015
A retrospective study of use of polyvalent anti-snake venom and risk factors for mortality from snake bite in a tertiary care settingShraddha M Pore, Sunita J Ramanand, Praveenkumar T Patil, et al.
American Journal of Public Health|May 10, 2011
Associations of fast food restaurant availability with dietary intake and weight among African Americans in the Jackson Heart Study, 2000-2004Demarc A Hickson, Ana V Diez Roux, Adam E Smith, et al.
Research Square|June 5, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroidsBeverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Cancer Chemotherapy and Pharmacology|September 12, 2025
RNA processing kinase inhibitors and epigenetic inhibitors in combination with oncology drugs or investigational agents in multi-cell type patient-derived tumor cell line spheroidsBeverly A Teicher, Thomas S Dexheimer, Thomas Silvers, et al.
Pageof 31